BPA Call HT001415A0010-HT001419F0068
Award Date 12/7/18
Potential Completion Date 9/30/19
Potential Value $60K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Clinton, MD 20735, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a Blanket Purchase Agreement (BPA) call awarded by the Defense Health Agency (DHA) to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The contract, valued at $27,445.00, is for the provision of micro reagents, kits, and consumables. It has a period of performance through May 20, 2025. The contract is not designated as a set-aside. Roche Diagnostics holds...
- This is a Blanket Purchase Agreement (BPA) awarded by the Defense Health Agency (DHA) to Roche Diagnostics Corporation for reagents and consumables for medical laboratory testing. The BPA is against VA Schedule Contract #V797P-7347A, which enables DHA to efficiently acquire Roche's diagnostic technologies through pre-negotiated pricing and terms. The contract has a ceiling value of $354,198.51 and a period of performance through May 2, 2025. No set-aside designation was used for this award....
- This is a Blanket Purchase Agreement (BPA) call awarded by the Defense Health Agency to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, laboratory instruments, and related medical products and services. The award has a ceiling value of $49,175.24 and covers the delivery of COBAS assays with a period of performance through September 30, 2025. The contract is a firm fixed-price arrangement and does not have a set-aside designation, indicating...
- This $650,000.00 firm fixed price Blanket Purchase Agreement (BPA) call was awarded by the Defense Health Agency (DHA) to Roche Diagnostics Corporation for reagents and consumables. The contract supports the DHA, a defense agency, and has no set-aside designation. Roche Diagnostics has been awarded multiple Indefinite Delivery Contracts and BPAs by federal agencies, including the Department of Veterans Affairs and Department of Defense, to provide a wide range of medical equipment,...
- The Defense Health Agency (DHA) awarded a $345,000 Blanket Purchase Agreement (BPA) call to Roche Diagnostics Corporation for immunology and clinical chemistry reagents, kits, and consumables. The award, finalized on September 21, 2025, with an ultimate completion date of September 30, 2025, represents a firm fixed-price delivery order under an existing BPA vehicle. The work will be performed at Roche Diagnostics' facility in Castleton, Indiana. This award was made without a set-aside...
- Roche Diagnostics Corporation received a Blanket Purchase Agreement (BPA) call award from the Defense Health Agency valued at $18,049.78 for reagents needed for testing. This child contract was awarded on October 1, 2025, with an ultimate completion date of September 30, 2026. The contract employs firm fixed-price pricing with no set-aside designation and is performed in Castleton, Indiana. As a firm fixed-price BPA call, this award represents a specific task order under an existing blanket...
- This is a Blanket Purchase Agreement (BPA) awarded by the Defense Health Agency (DHA) to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for the procurement of reagents and consumables. The BPA is established against Roche's existing General Services Administration (GSA) Schedule contract for Critical Analyzers, Laboratory (FSS-66-III). The contract has a 5-year ordering period with a ceiling value of $356,540.11. Roche Diagnostics, a manufacturer and distributor of in...
- This federal contract award was issued by the Defense Health Agency (DHA), a defense agency, to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics and laboratory equipment. The $2,800,000.00 Blanket Purchase Agreement (BPA) Call contract is for the provision of reagents and peripheral consumables. The contract is not designated as a set-aside. Roche Diagnostics holds multiple Indefinite Delivery Vehicles (IDVs) and BPAs with federal agencies such as...
- The Defense Health Agency awarded a $43,010 Blanket Purchase Agreement (BPA) call to Roche Diagnostics Corporation on April 22, 2025, for the provision of micro BPA reagents, kits, and consumables. This contract is a child award under a larger BPA vehicle and carries a firm fixed price structure with no set-aside designation. The work will be performed at Wright-Patterson Air Force Base in Ohio, with an ultimate completion date of April 24, 2025. Roche Diagnostics Corporation, a foreign-owned...
- This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the Defense Health Agency (DHA) to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, laboratory instruments, and medical products. The $68,867.25 contract is for TESTING SERVICES and has a completion date of September 30, 2025. The award is not a set-aside contract. Roche Diagnostics holds multiple significant Indefinite Delivery Vehicles (IDVs) and BPAs across federal...